Drug Resistance in Leishmania Parasites

Prologue.- Introduction.- Part I Determinant features in Leishmaniasis.- Molecular evolution and phylogeny of Leishmania.- The role of reservoirs: canine Leishmaniasis.- Epidemiology of Leishmaniasis in the time of drug resistance.- The role of the immune system in resistance to infection.- Part II Challenges in the diagnosis, treatment and control of Leishmaniasis in the times of drug resistance.- Co-infection with HIV.- Visceral Leishmaniasis.- Tegumentary Leishmaniasis.- Antimony accounted sequel post Kala-Azar dermal Leishmaniasis.- Part III Molecular featrues of drug resistant Leishmania.- Genetic Expression and drug resistance, the role of proteomics.- The role of AMC transporters in drug-resistant Leishmania.- Functional analysis of Leishmania membrane (non AMC) transporters involved in drug resistance.- Part IV Pharmacology and chemotherapy of Leishmaniasis.- Classical vs. novel treatment regimens.- Bioinformatics in Leishmania drug design.- Leishmanis mitochondria, a druggable organelle.- P-glycoprotein-like transporters in Leishmania: a search for reversal agents.- Part V Strategies to circumvent drug resistance in Leishmania.- The relevance of susceptibility tests, breakpoints and markers.- The concept of fitness in Leishmania.

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Microbiologia (não médica)
• Tecnologia farmacêutica
• Doenças infecciosas e contagiosas
• Parasitologia médica
• Farmacologia
• Imunologia

ABC Transporters;Drug Resistance;Infectious Disease;Leishmaniasis;Parasite;Vaccine Development;antibacterial drug resistance;infectious diseases;vaccines